ALK and cancer: Because both A549 and Panc-1 are KRAS mutant cancer cell lines, we next checked the effects of COPS5 knock-down in H1650 or H2228 lung adenocarcinoma cell lines, which has an EGFR mutation or EML4-ALK fusion, respectively.